ArticleJournal of Korean medical science2016

Pretreatment Lymphopenia, Poor Performance Status, and Early Courses of Therapy Are Risk Factors for Severe Bacterial Infection in Patients with Multiple Myeloma during Treatment with Bortezomib-based Regimens.

Shin Young Hyun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.